This strategic role is focused on securing and maintaining market access for Abbott’s innovative cardiovascular and neuromodulation (CV&N) technologies through proactive engagement with U.S. private Payers and affiliated entities.
Base: $129,300.00 – $258,700.00; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified